Literature DB >> 18094173

The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread.

Rojjanaporn Pulmanausahakul1, Jianwei Li, Matthias J Schnell, Bernhard Dietzschold.   

Abstract

While the glycoprotein (G) of rabies virus (RV) is known to play a predominant role in the pathogenesis of rabies, the function of the RV matrix protein (M) in RV pathogenicity is not completely clear. To further investigate the roles of these proteins in viral pathogenicity, we constructed chimeric recombinant viruses by exchanging the G and M genes of the attenuated SN strain with those of the highly pathogenic SB strain. Infection of mice with these chimeric viruses revealed a significant increase in the pathogenicity of the SN strain bearing the RV G from the pathogenic SB strain. Moreover, the pathogenicity was further increased when both G and M from SB were introduced into SN. Interestingly, the replacement of the G or M gene or both in SN by the corresponding genes of SB was associated with a significant decrease in the rate of viral replication and viral RNA synthesis. In addition, a chimeric SN virus bearing both the M and G genes from SB exhibited more efficient cell-to-cell spread than a chimeric SN virus in which only the G gene was replaced. Together, these data indicate that both G and M play an important role in RV pathogenesis by regulating virus replication and facilitating cell-to-cell spread.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18094173      PMCID: PMC2258906          DOI: 10.1128/JVI.02327-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.

Authors:  Jianwei Li; Milosz Faber; Amy Papaneri; Marie-Luise Faber; James P McGettigan; Matthias J Schnell; Bernhard Dietzschold
Journal:  Virology       Date:  2006-08-30       Impact factor: 3.616

2.  Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus.

Authors:  M J Schnell; L Buonocore; E Boritz; H P Ghosh; R Chernish; J K Rose
Journal:  EMBO J       Date:  1998-08-10       Impact factor: 11.598

Review 3.  The application of reverse genetics technology in the study of rabies virus (RV) pathogenesis and for the development of novel RV vaccines.

Authors:  Matthias J Schnell; Gene S Tan; Bernhard Dietzschold
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

4.  Spread and pathogenic characteristics of a G-deficient rabies virus recombinant: an in vitro and in vivo study.

Authors:  Réza Etessami; Karl-Klaus Conzelmann; Babak Fadai-Ghotbi; Benjamin Natelson; Henri Tsiang; Pierre-Emmanuel Ceccaldi
Journal:  J Gen Virol       Date:  2000-09       Impact factor: 3.891

5.  The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral transcription.

Authors:  Gene S Tan; Mirjam A R Preuss; John C Williams; Matthias J Schnell
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

6.  Identification of viral genomic elements responsible for rabies virus neuroinvasiveness.

Authors:  Milosz Faber; Rojjanaporn Pulmanausahakul; Kazuhiko Nagao; Mikhail Prosniak; Amy B Rice; Hilary Koprowski; Matthias J Schnell; Bernhard Dietzschold
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-01       Impact factor: 11.205

7.  Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures.

Authors:  K Morimoto; D C Hooper; S Spitsin; H Koprowski; B Dietzschold
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter.

Authors:  U J Buchholz; S Finke; K K Conzelmann
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus.

Authors:  Milosz Faber; Marie-Luise Faber; Jianwei Li; Mirjam A R Preuss; Matthias J Schnell; Bernhard Dietzschold
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

10.  Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus.

Authors:  C Tuffereau; J Bénéjean; D Blondel; B Kieffer; A Flamand
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

View more
  28 in total

1.  Molecular basis of neurovirulence of flury rabies virus vaccine strains: importance of the polymerase and the glycoprotein R333Q mutation.

Authors:  Lihong Tao; Jinying Ge; Xijun Wang; Hongyue Zhai; Tao Hua; Bolin Zhao; Dongni Kong; Chinglai Yang; Hualan Chen; Zhigao Bu
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

2.  Involvement of the rabies virus phosphoprotein gene in neuroinvasiveness.

Authors:  Satoko Yamaoka; Naoto Ito; Seii Ohka; Shohei Kaneda; Hiroko Nakamura; Takahiro Agari; Tatsunori Masatani; Keisuke Nakagawa; Kazuma Okada; Kota Okadera; Hiromichi Mitake; Teruo Fujii; Makoto Sugiyama
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  Gene order rearrangement of the M gene in the rabies virus leads to slower replication.

Authors:  Xian-Feng Yang; Jiao-Jiao Peng; Hong-Ru Liang; You-Tian Yang; Yi-Fei Wang; Xiao-Wei Wu; Jiao-Jiao Pan; Yong-Wen Luo; Xiao-Feng Guo
Journal:  Virusdisease       Date:  2014-06-07

4.  Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccine.

Authors:  Amy B Papaneri; John G Bernbaum; Joseph E Blaney; Peter B Jahrling; Matthias J Schnell; Reed F Johnson
Journal:  Virus Res       Date:  2014-12-04       Impact factor: 3.303

5.  PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity.

Authors:  Christoph Wirblich; Gene S Tan; Amy Papaneri; Peter J Godlewski; Jan Marc Orenstein; Ronald N Harty; Matthias J Schnell
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

6.  Intergenotypic replacement of lyssavirus matrix proteins demonstrates the role of lyssavirus M proteins in intracellular virus accumulation.

Authors:  Stefan Finke; Harald Granzow; Jose Hurst; Reiko Pollin; Thomas C Mettenleiter
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

7.  Characterization of a single-cycle rabies virus-based vaccine vector.

Authors:  Emily A Gomme; Elizabeth J Faul; Phyllis Flomenberg; James P McGettigan; Matthias J Schnell
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

Review 8.  Everything You Always Wanted to Know About Rabies Virus (But Were Afraid to Ask).

Authors:  Benjamin M Davis; Glenn F Rall; Matthias J Schnell
Journal:  Annu Rev Virol       Date:  2015-06-24       Impact factor: 10.431

Review 9.  The cell biology of rabies virus: using stealth to reach the brain.

Authors:  Matthias J Schnell; James P McGettigan; Christoph Wirblich; Amy Papaneri
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

10.  Concepts in the pathogenesis of rabies.

Authors:  Bernhard Dietzschold; Jianwei Li; Milosz Faber; Matthias Schnell
Journal:  Future Virol       Date:  2008-09       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.